Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients. Pjmcr [Internet]. 2026 Jan. 21 [cited 2026 Jul. 31];5(1):163-74. Available from: https://pakjmcr.com/index.php/1/article/view/492